Related Experiment Video
Updated: Mar 19, 2026
12:08
Novel Protocol for Generating Physiologic Immunogenic Dendritic Cells
Published on: May 17, 2019
9.8K
Immunomodulation of immunothrombocytopenia.
1Institute of Genetics, Department of Biology, University of Erlangen-Nürnberg, Erlangen, Germany.
Seminars in Hematology
|June 18, 2016
Summary
New immunothrombocytopenia (ITP) treatments target Fc-receptors, which mediate platelet destruction. This approach offers a more specific alternative to generalized immunosuppression for ITP management.
Area of Science:
- Immunology
- Hematology
- Pharmacology
Background:
- Current immunothrombocytopenia (ITP) treatments involve immunosuppression or platelet production stimulation.
- Recent research highlights Fc-receptors' role in autoantibody-mediated platelet destruction in ITP.
Purpose of the Study:
- To review novel therapeutic strategies for ITP focused on Fc-receptor pathways.
- To discuss methods for targeting autoantibody-mediated platelet depletion.
Main Methods:
- Review of recent research on Fc-receptor function in ITP.
- Discussion of therapeutic approaches interfering with Fc-receptor-mediated pathways.
Main Results:
- Fc-receptors are critical in autoantibody-mediated platelet clearance.
- Targeting Fc-receptor interactions offers a specific therapeutic avenue for ITP.
Conclusions:
- Interfering with Fc-receptor pathways presents a promising, targeted strategy for ITP treatment.
- Future ITP therapies may focus on preventing immune complex-Fc-receptor interactions or modulating signaling pathways.
Related Concept Videos
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
653
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
653
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
1.5K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.5K
01:27Tumor Immunotherapy
2.1K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.1K
01:01Regulation of Hematopoietic Stem Cells
4.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
4.3K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
909
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
909
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
2.3K
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
2.3K